Study to Evaluate the Efficacy of the décoLITE LED Device in Treating the Signs of Skin Aging of the décolletage Area

Inclusion Criteria: * Healthy female, 30 to 65 years of age. * Fitzpatrick phototype I-VI skin. * Gave written informed consent. * Photoaging of the décolletage area. * Agreed NOT to use anti-aging products that contain active ingredients such as retinol and glycolic acid on the treatment area during the study period. * Agreed NOT to undergo any aesthetic treatments (such as chemical peels, microdermabrasion, laser surfacing, etc.) in the treatment area during the study period Exclusion Criteria: * Suffering from a systemic photosensitive disorder such as Lupus erythematosus, photosensitive eczema, or Albinism. * Currently taking (or with a history of taking) medication that is known to induce photosensitivity. * Having known malignancy and/or undergoing chemotherapy, radiotherapy, or high doses of corticosteroids. * Suffering from keloid scars or birth marks in the treatment area. * Suffering from eczema, psoriasis, or skin rashes in the treatment area. * Had used an anti-aging product within the 4 weeks prior to commencing the study. * Underwent plastic surgery within the last 6 months. * Pregnant, breast-feeding, or wishing to become pregnant during the study period. * Being enrolled in another clinical trial during the same study period. * Having a planned hospital admission and/or surgical procedure for an illness or disease which existed before enrollment into the clinical trial, and which may interfere with the course or outcome of the study. * Having medical or psychological condition(s) associated with a risk of poor protocol compliance (e.g., alcoholism or drug abuse). * Undergoing or is likely to undergo other treatments of the décolletage area.